Surrey Heartlands

Joint Formulary & PAD

Zidovudine - Prevention of HIV vertical transmission

You are here : Home > Formulary Search > Zidovudine - Prevention of HIV vertical transmission

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Not Specified
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
NHSE
R
Restrictions / Comments :
Important
Restricted use - prevention of vertical transmission in babies born to HIV-positive mothers. Use as recommended in BHIVA guidelines

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Zidovudine
Indication :
Prevention of HIV vertical transmission
Group Name :
Keywords :
antiviral, vertical transmission, HIV prophylaxis, mothers, babies, peri-natal
Brand Names Include :
Retrovir
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Zidovudine is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Prevention of HIV vertical transmission.

Committee Recommendations (1)

04 Sep 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

These drugs falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care.

Clinicians / specialists within the Acute setting should only prescribe in line with their Trust formulary / pharmacy advice.

GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication